TSH Biopharm Corporation Limited
8432
Rank in Stocks
#21201
TSH Biopharm Corporation Limited, a subsidiary of TTY Biopharm Company Limited,... TSH Biopharm Corporation Limited, a subsidiary of TTY Biopharm Company Limited, specializes in the development and commercialization of pharmaceutical products. Established in 1999 with its headquarters in Taipei, Taiwan, the company's market reach extends across Taiwan and other Asian territories. Its product portfolio encompasses a variety of therapeutic solutions, including treatments for cardiovascular, central nervous system, and gastrointestinal conditions, among others.
Share Price
$1.87
Last synced: 2026-11-10
Market Cap
$71.87M
Change (1 day)
0.00%
Change (1 year)
7.03%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TSH Biopharm Corporation Limited (8432)
Category
Healthcare
EPS for TSH Biopharm Corporation Limited (8432)
EPS as of September 2026 TTM: $0.17
According to TSH Biopharm Corporation Limited's latest financial reports, its current EPS (TTM) is $0.17. At the end of 2025 the company had an EPS of $0.12, an increase over its 2024 EPS of $0.09.
EPS history for TSH Biopharm Corporation Limited from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.17 | 40.50% |
| 2025 | $0.12 | 29.13% |
| 2024 | $0.09 | 70.67% |
| 2023 | $0.05 | 0.00% |
| 2022 | $0.05 | 18.24% |
| 2021 | $0.04 | -22.11% |
| 2020 | $0.06 | -23.18% |
| 2019 | $0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 3,756.11% |
DE
|
|
| $6.08 | 3,504.74% |
DE
|
|
| $1.55 | 819.69% |
JP
|
|
| $3.66 | 2,070.82% |
CH
|
|
| $0.45 | 166.90% |
IL
|
Questions about TSH Biopharm Corporation Limited's earnings per share (EPS)
What is TSH Biopharm Corporation Limited's earnings per share (EPS)?
TSH Biopharm Corporation Limited's earnings per share (EPS) over the last twelve months is $0.17, as of Sep 2026.
What was TSH Biopharm Corporation Limited's earnings per share (EPS) in 2025?
In 2025, TSH Biopharm Corporation Limited's earnings per share (EPS) was $0.12, 33.33% more than in 2024 ($0.09).
How has TSH Biopharm Corporation Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, TSH Biopharm Corporation Limited's earnings per share (EPS) went from $0.06 to $0.12, an average growth of 14.87% a year.
How does TSH Biopharm Corporation Limited's earnings per share (EPS) compare with similar companies?
TSH Biopharm Corporation Limited's earnings per share (EPS) ($0.17) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.